BioIntelliSense Closes Oversubscribed $45M Series B Financing Round to Scale Its Data-as-a-Service and Clinical Intelligence Platform
Strategic funding will support company’s growth and global expansion of continuous multi-parameter monitoring devices and data services for medical grade